Found 0 matching trials
A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD PHASE1 This study is designed to assess the efficacy and safety of multiple intrav...
Show More Location
Beijing Tongren Hospital
Learn More & Join Trial
Open Label Extension Study of AMG 531 in Japanese Subjects With ITP PHASE2 The purpose of this study is to assess the safety and efficacy of long term...
Show More Learn More & Join Trial
(-)- Epicatechin Becker Muscular Dystrophy PHASE2 This is a 48-week open-label extension of our initial proof-of-concept stud...
Show More Location
UC Davis Medical Center
Learn More & Join Trial
Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h PHASE1 Demonstrate bioequivalence of guaifenesin in Mucinex® extended release (ER)...
Show More Location
Multiple Locations
Learn More & Join Trial
Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease PHASE3 This 12-month study had two phases: a 90-day double-blind, randomized, plac...
Show More Location
Rivercity Research
Learn More & Join Trial
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488. PHASE3 The purpose of this study is to determine if long-term treatment, up to 1 y...
Show More Location
Global Medical Information - Abbott
Learn More & Join Trial
Comparing the Therapeutic Efficacy of Extended Isthmusectomy Versus Total Thyroidectomy for Isthmus Tumors of the Thyroid NA Prospective randomized open phase III non-inferiority trial in cT1bN0N1aM0 ...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Learn More & Join Trial
Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients PHASE3 To evaluate the safety of long-term administration of sirolimus oral soluti...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures PHASE3 This was an open-label extension study in adolescent and adult (between 12 ...
Show More Location
University of South Alabama Medical Center
Learn More & Join Trial
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) PHASE3 The main objectives of Part 1 are as follows: To evaluate the safety, toler...
Show More Location
Boston Children's Hospital
Learn More & Join Trial